Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameTHE SUNLIGHT OMNISENSE(TM) ULTRASOUND BONE SONOMETER
Classification Namebone sonometer
Generic Nameultrasound bone sonometer
Regulation Number892.1180
ApplicantBEAM-MED LTD
PMA NumberP990035
Date Received06/30/1999
Decision Date01/20/2000
Reclassified Date 08/18/2008
Product Code
MUA[ Registered Establishments with MUA ]
Docket Number 00M-0577
Notice Date 02/16/2000
Advisory Committee Radiology
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
The sumlight omnisense ultrasound bone sonometer is a non-invasive device that is designed for the quantitative measurement of the velocity of ultrasound waves ("speed of sound" or "sos in m/sec") propagating along the distal one-third of the radius bone. Sos provides a measure of skeletal fragility. The output is also expressed as a t-score and z-score and can be used in conjunction with other clinical risk factors as an aid to the physician in diagnosis of osteoporosis and other medical conditions leading to reduced bone strength and, ultimately, in the determination of fracture risk. The sos measured by omnisense has a precision error low enough in comparison with the expected annual change in a pateints' measurement to make it suitable for monitoring bone changes which occur in the early years following menopause (i. E. , age range approximately 50-65 years).
Approval Order Approval Order
Supplements: S001 S002 S003 S004 S005 S006 
-
-